Interventional Pulmonology Market is estimated to surge ahead at a CAGR of 4.2% to reach US$ 1.9 Bn by the end of 2033 | Medtronic Plc, Boston Scientific Corporation, Olympus Corporation

Interventional pulmonology is a subspecialty of pulmonology that focuses on the use of minimally invasive procedures to diagnose and treat lung diseases and conditions. These procedures are typically performed using bronchoscopes and other specialized instruments, and they are designed to be less invasive and more precise than traditional surgery.

Request For Free Sample Report of "Interventional Pulmonology Market"@ https://www.persistencemarketresearch.com/samples/3036

The market for interventional pulmonology is expected to see significant growth in the coming years due to the increasing prevalence of lung diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, and the growing demand for minimally invasive treatments. In addition, the development of advanced bronchoscopy technologies, such as virtual bronchoscopy and electromechanical bronchoscopy, is expected to drive the market.

Worldwide revenue from the interventional pulmonology market stands at US$ 1.2 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 4.2% to reach a valuation of US$ 1.9 Bn by the end of 2033.

As assessed by Persistence Market Research, hospitals segment is expected to hold a largest market value of US$ 546.6 Mn by 2023. Overall, interventional pulmonology market sales account for approximately 6.2% revenue share in the global respiratory devices market, which was valued at around US$ 19.5 Bn at the end of 2022.

 Companies

Medtronic Plc
Boston Scientific Corporation
Olympus Corporation
FUJIFILM Corporation
Becton, Dickinson and Company
Smith's Group Plc
Cook Medical
Vygon
Clarus Medical LLC
Huger Medical Instrument Co. Ltd
Taewoong Medical Co. Ltd.

 Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/3036

Geographically, the market for interventional pulmonology is expected to be dominated by North America and Europe due to the high demand for minimally invasive treatments and the presence of well-established healthcare infrastructure in these regions. However, the market in Asia Pacific is expected to grow at a significant rate due to the increasing prevalence of lung diseases and the growing healthcare infrastructure in the region.

Overall, the market for interventional pulmonology is expected to see strong growth in the coming years due to the increasing prevalence of lung diseases and the growing demand for minimally invasive treatments.

Competition Landscape

Due to industry consolidation, major players are focusing more on acquiring local and regional market players. This trend has been especially evident in the Asia-Pacific region. Big players in the acquisition space are players with sizable regional distribution networks in terms of direct sales force and equipped manufacturing facilities for interventional pulmonary treatment products.

Key instances include:

In Aug 2020, The BF-Q180 bronchoscope from Olympus Corporation was recalled because it failed a 510(k) clearance and was linked to a greater rate of patient infections than other bronchoscopes from Olympus Medical Systems Corporation.

In May 2020, the introduction of artificial intelligence, high definition image, and sophisticated data processing were few of the accomplishments and initiatives that Fujifilm Holdings Corporation announced in relation to the expansion of their endoscopy and endoscopic health portfolio.

 Request Customization @ https://www.persistencemarketresearch.com/request-customization/3036

Key Segments Covered in Interventional Pulmonology Industry Research

Product:

Bronchoscopes

Fiberoptic (flexible) Bronchoscope

Rigid bronchoscope

Endobronchial Ultrasound Bronchoscope (EBUS)

Convex EBUS

Radial EBUS

Respiratory Endotherapy Devices

Aspiration Needles

Biopsy Forceps

Other

ENB Systems

Pleuroscopes

Semi flexible Pleuroscopes

Rigid Pleuroscopes

Airway Stents

Bronchial Thermoplasty Systems

Pleural Catheters

Endobronchial Valves

 

Indication:

Lung Cancer

Asthma

COPD

Foreign Body Extraction

Tracheal and Bronchial Stenosis

Others

 

End User:

Hospitals

Pulmonology Clinics

Ambulatory Surgical Centers

Diagnostic Centers

For More Premium Insights, Check out the Link:

Antibody Testing Market - https://www.prnewswire.com/news-releases/antibody-testing-market-is-expected-to-exhibit-a-cagr-of-around-7-7-over-the-forecast-period-2021-2031-301436920.html

Sleep Aids Market - https://www.prnewswire.com/news-releases/sleep-aids-market-is-expected-to-register-a-cagr-of-4-5-during-the-forecast-period-2021-2031-301436923.html

Digital Pcr Market - https://www.prnewswire.com/news-releases/digital-pcr-market-is-expected-to-exhibit-a-cagr-of-around-9-3-over-the-forecast-period-2021-2031-301436094.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research's Expertise in Life Sciences and Transformational Health

Our expert team of industry analysts comprising management graduates, medical professionals, engineers, and project managers provides insights on emerging therapy areas, diagnostic tools, medical devices and components, reimbursement and market access, biotechnology, and life science research products and services to equip decision-makers with sound inputs and strategic recommendations. Click here to learn more about how we zero in on the critical aspects of this industry.

This release was published on openPR.